Clinical Presentations

  This week, we continue our Homerun Slides series on Hypo and Hyperglycemia focusing in on Hypoglycemia in the hospital. Although hypoglycemia is easily treatable, the medications used are also subject to errors and included in this week’s collection of slides is a dramatic and tragic demonstration of what can …

In this week’s Homerun Slides, we cover how to help patients determine the correct time and amount of insulin dosage, examine the perils of sliding scales, and also give you the basics on how to deal with different degrees of hypoglycemia….

This week, we have Part 2 of our Homerun Slides on Hypo and Hyperglycemia focusing on how different types of insulin can result in various effects which if not managed correctly, may result in hypoglycemia…

This week we begin a new Homerun Slides series covering Hypo and Hyperglycemia from our Editor-in-chief, Dave Joffe, BSPharm, CDE, FACA, which will include facts and figures on this burgeoning epidemic.

This week we wrap up our nine-part series of Homerun Slides on An Aggressive Pathophysiologic Approach to Cardiometabolic Therapy for Type 2 Diabetes with information on Therapy for Type II Diabetes, Non-Insulin Therapy for Type II Diabetes, Concurrent Therapy….

In this week’s Homerun Slides, Part 8 of Dr. Stanley Schwartz’s series on An Aggressive Pathophysiologic Approach to Cardiometabolic Therapy for Type 2 Diabetes, we continue with our discussion last week of the benefits of Ranolazine for diabetes patients….

In this week’s continuation of our Homerun Slides series from Dr. Stanley Schwartz, we delve into the effects of Ranolazine on A1c and some of the studies done exploring the CV effects as well ….

In this week’s Homerun Slides, we present Part 6 of Dr. Stanley Schwartz’s series on An Aggressive Pathophysiologic Approach to Cardiometabolic Therapy for Type 2 Diabetes, in which we will look closely at at "Modern Insulin Resistant Man" who is locked into "Seasonal Insulin Resistance Syndrome Physiology"….

In this week’s Homerun Slides, we cover such topics as the Potential Mechanisms of reducing CV outcomes with DPP-4 inhibitors, Mechanisms of Incretins, and Insulin Secretagogues: Sulfonylureas and "Glinides"…

In this week’s Homerun Slides, we continue with Part 4 of our series from Dr. Stanley Schwartz on An Aggressive Pathophysiologic Approach to Cardiometabolic Therapy for Type 2 Diabetes. This week’s topics include a look at Pioglitazone, the Natural History of Type 2 Diabetes – Insulin Secretion, and the CV Benefits of …